Ultime notizie per Verra Mobility (NASDAQ:VRRM) Azioni

Verra Mobility

Verra Mobility Corp provides smart transportation solutions. The company develops and uses technology and data intelligence to help make transportation safer and easier. It operates in three segments namely Commercial Services, Government Solutions, and Parking Solutions. It generates maximum revenue from the Commercial Services segment. The commercial Services segment delivers tolling and violation management services to rental car companies, commercial fleet vehicle owners, and violation issuing authorities.

Verra Mobility Corporation - Class A Common Stock

Verra Mobility Corp

Verra Mobility Corp Warrants (17/10/2023)

Applovin Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) shares are ripping higher in Wednesday&#8217;s after-hours session on the heels of the company&#8217;s third-quarter financial results. Here&#8217;s a <a href="https://www.benzinga.com/pressreleases/24/11/b41786448/applovin-announces-third-quarter-2024-financial-results">rundown of the report</a>.
<ul>
<li>Q3 Revenue: $1.2 billion, versus <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $1.13 billion</li>
</ul>
<ul>
<li>Q3 EPS: $1.25, versus estimates of 94 cents</li>
</ul>
Total revenue was up 39% year-over-year. Software platform revenue increased 66% year-over-year, while Apps revenue grew 1%. Cash flow from operations was $551 million in the quarter and free cash flow came in at $545 million. Applovin ended the quarter with $568 million in cash and cash equivalents. 
Applovin&#8217;s board increased the company&#8217;s share repurchase program by $2 billion. The company said it now has $2.3 billion remaining under the buyback. The company expects to fund future repurchases with free cash flow.
&#8220;We had another fantastic quarter in the third quarter. Our AXON models continue to improve through self-learning and, more importantly this quarter, from technology enhancements by our engineering team. As we continue to improve our models our advertising partners are able to successfully spend at a greater scale,&#8221; the company said in a letter to shareholders.
Outlook: Applovin expects fourth-quarter revenue to be in the range of $1.24 billion to $1.26 billion. The company expects fourth-quarter adjusted EBITDA to be in the range of $740 million to $760 million.
Management is currently discussing the quarter on a conference call that kicked off at 5 p.m. ET.
APP Price Action: <a href="http://benzinga.com/quote/app">Applovin shares</a> were up 28.15% after hours at $216 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next: • <a href="https://www.benzinga.com/news/earnings/24/11/41789162/lyft-stock-drives-higher-after-better-than-expected-q3-results">Lyft Stock Drives Higher After Better-Than-Expected Q3 Results</a>
Photo: Pixabay.

Earnings

News

Guidance

After-Hours Center

Movers

Applovin Stock Soars After Q3 Earnings Report: Revenue Beat, EPS Beat, Strong Software Platform Growth

Biotech

General

CPIX

Cumberland Pharmaceuticals Receives FDA Orphan Drug, Rare Pediatric Disease Designations For New Treatment Of Duchenne Muscular Dystrophy

Myomo (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MYO#AMEX">MYO</a>) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.04) by 25 percent. This is a 50 percent increase over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $9.208 million which beat the analyst consensus estimate of $8.110 million by 13.53 percent. This is a 81.26 percent increase over sales of $5.080 million the same period last year.

Earnings Beats

Myomo Q3 2024 GAAP EPS $(0.03) Beats $(0.04) Estimate, Sales $9.208M Beat $8.110M Estimate

ARDT

Ardent Health Raises FY24 Revenue To $5.8B-$5.875B From $5.75B-$5.9B; Updates Diluted EPS To $1.18-$1.32 From $1.23-$1.37

SENEA

Seneca Foods Q2 Revenue $425.5M Up From $407.5M YoY

Full House Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLL#NASDAQ">FLL</a>) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.10) by 140 percent. This is a 284.62 percent decrease over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $75.687 million which missed the analyst consensus estimate of $78.918 million by 4.09 percent. This is a 5.79 percent increase over sales of $71.543 million the same period last year.

Earnings Misses

Full House Resorts Q3 2024 GAAP EPS $(0.24) Misses $(0.10) Estimate, Sales $75.687M Miss $78.918M Estimate

Select Medical Holdings Corporation Declares Special Stock Distribution To Spin-Off Concentra; Estimates Stockholders Will Receive Approximately 0.806971 Shares Of Concentra's Common Stock For Every Share Of Select Medical's Common Stock Held As Of The Close Of Business On The Record Date

Algoma Steel Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTL#NASDAQ">ASTL</a>) reported quarterly losses of $(0.72) per share which missed the analyst consensus estimate of $(0.27) by 166.67 percent. This is a 500 percent decrease over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $440.03 million which missed the analyst consensus estimate of $568.90 million by 22.65 percent. This is a 19.42 percent decrease over sales of $546.10 million the same period last year.

ASTL

Algoma Steel Gr Q2 EPS $(0.72) Misses $(0.27) Estimate, Sales $440.03M Miss $568.90M Estimate

Global Medical REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMRE#NYSE">GMRE</a>) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.20 by 10 percent. This is a 4.35 percent decrease over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $34.175 million which missed the analyst consensus estimate of $34.645 million by 1.36 percent. This is a 3.70 percent decrease over sales of $35.487 million the same period last year.

GMRE

Global Medical REIT Q3 2024 FFO $0.22 Beats $0.20 Estimate, Sales $34.175M Miss $34.645M Estimate

The company remains on track for a topline Phase 1 data readout by the end of the year.

SABS

SAB BIO Says Co Completed Phase 1 Enrollment For SAB-142 With No Observation Of Serum Sickness

SAB BIO Q3 2024 Cash, Cash Equivalents Available $30.4M-$56.6M

Granite Point Mortgage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPMT#NYSE">GPMT</a>) reported quarterly losses of $(0.75) per share which beat the analyst consensus estimate of $(0.82) by 8.54 percent. The company reported quarterly sales of $7.658 million which missed the analyst consensus estimate of $10.598 million by 27.74 percent. This is a 61.55 percent decrease over sales of $19.915 million the same period last year.

GPMT

Granite Point Mortgage Q3 2024 Adj. EPS $(0.75) Beats $(0.82) Estimate, Sales $7.658M Miss $10.598M Estimate

Trevi Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVI#NASDAQ">TRVI</a>) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.12) by 8.33 percent. This is a 62.5 percent decrease over losses of $(0.08) per share from the same period last year.

TRVI

Trevi Therapeutics Q3 2024 GAAP EPS $(0.13) Misses $(0.12) Estimate

VIRX

Viracta Therapeutics To Reprioritize Resources To Focus On Nana-val Development Program In Relapsed Or Refractory EBV-Positive Peripheral T-Cell Lymphoma; Announces 42% Force Reduction, Sees $700K In Total Expenses

Ardent Health Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARDT#NYSE">ARDT</a>) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.30 by 36.67 percent. The company reported quarterly sales of $1.45 billion which met the analyst consensus estimate. This is a 5.22 percent increase over sales of $1.38 billion the same period last year.

Ardent Health Partners Q3 2024 GAAP EPS $0.19 Misses $0.30 Estimate, Sales $1.45B Inline

Offerings

ALKT

Alkami Launches Proposed Secondary Offering Of 7.5M Shares

Dutch Bros Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BROS#NYSE">BROS</a>) shares are up after the company reported its third-quarter results after Wednesday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/24/11/b41786518/dutch-bros-inc-reports-third-quarter-2024-financial-results">details from the report.</a>
The Details: Dutch Bros reported quarterly earnings of 16 cents per share, which beat the analyst consensus estimate of 12 cents. Quarterly revenue came in at $338.21 million, which beat the analyst consensus estimate of $325.14 million and is an increase over sales of $264.51 million from the same period last year.
<ul>
<li>Dutch Bros opened 38 new shops, 33 were company-operated, across 11 states.</li>
<li>System same-shop sales and transactions increased 2.7% and 0.8%, respectively, relative to the same period in 2023.</li>
<li>Company-operated same-shop sales and transactions increased 4% and 2.4%, respectively, relative to the same period of 2023.</li>
<li>Company-operated shop revenues increased 30.4% to $308.3 million, as compared to $236.5 million in the same period last year. </li>
</ul>
Read Next: <a href="https://www.benzinga.com/news/24/11/41781921/what-does-trumps-victory-mean-for-ev-giant-tesla-and-the-big-3-automakers">What Does Trump&#8217;s Victory Mean For EV Giant Tesla And The Big 3 Automakers?</a>
&#8220;We delivered exceptional performance in the third quarter as we executed our strategic and operational initiatives. We believe our brand is resonating with customers, as we had the highest same-shop transaction growth quarter in two years, outside of the impact of Leap Day. In the third quarter we delivered a 28% revenue increase and systemwide same-shop sales growth of 2.7%, which exceeded our expectations,&#8221; said Christine Barone, CEO of Dutch Bros.
Outlook:&nbsp;The company raised its fiscal year total revenues to be between $1.255 billion and $1.26 billion, up from the prior range of $1.215 billion to $1.23 billion.
BROS Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Dutch Bros shares are up 15.20% after-hours at $40.25 at the time of publication Wednesday.
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/11/41774549/trumps-big-tech-policies-what-gop-victory-means-for-apple-google-microsoft">Trump&#8217;s Big Tech Policies: What GOP Victory Means For Apple, Google, Microsoft</a></li>
</ul>
Photo: Courtesy of Dutch Bros Inc.

Restaurants

BROS

Dutch Bros Stock Perks Up After Solid Q3 Earnings Report: Details

Manulife Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MFC#NYSE">MFC</a>) reported quarterly earnings of $1.00 per share which beat the analyst consensus estimate of $0.94 by 6.38 percent. The company reported $1.800 billion in sales this quarter. This is a 35.44 percent increase over sales of $1.329 billion the same period last year.

Manulife Financial Q3 2024 Adj. EPS $1.00 Beats $0.94 Estimate, Sales $1.800B Up From $1.329B YoY

Marathon Oil Raises 2024 Total Oil Production Guidance To 192,000 Net Bopd And Oil Equivalent Guidance To 393,000 Net Boed, While Leaving Original Capital Spending Guidance Range Unchanged

Kronos Worldwide (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRO#NYSE">KRO</a>) reported quarterly sales of $484.70 million which missed the analyst consensus estimate of $569.54 million by 14.90 percent. This is a 22.12 percent increase over sales of $396.90 million the same period last year.

Kronos Worldwide Q3 Sales $484.70M Miss $569.54M Estimate

Reports Q3 revenue $225.6M, consensus $226.64M. "We delivered a solid third quarter, highlighted by strong revenue, earnings, and cash flow generat...

Verra Mobility reports Q3 adjusted EPS 32c, consensus 32c

Consensus for 2024 EPS is $1.20. Still sees 2024 total revenue at upper-end of $865M-$880M, consensus $880.54M. Published first on TheFly – the ult...

Verra Mobility still sees 2024 adjusted EPS at upper end of $1.15-$1.20

Verra Mobility ( ($VRRM) ) has issued an announcement. Verra Mobility reported a strong third quarter of 2024, with a 7% increase in total revenue ...

Verra Mobility Reports Strong Q3 2024 Performance

Verra Mobility Corporation 2024 Q3 - Results - Earnings Call Presentation

Verra Mobility Non-GAAP EPS of $0.32, revenue of $225.6M

Verra Mobility Corporation (VRRM) Q3 2024 Earnings Call Transcript

Verra Mobility ( ($VRRM) ) has released its Q3 earnings. Here is a breakdown of the information Verra Mobility presented to its investors. Verra Mo...

Verra Mobility Reports Strong Q3 2024 Results

Baird lowered the firm's price target on Verra Mobility (VRRM) to $28 from $29 and keeps a Neutral rating on the shares. The firm said Q3 results o...

Verra Mobility price target lowered to $28 from $29 at Baird

Deutsche Bank lowered the firm's price target on Verra Mobility (VRRM) to $29 from $31 and keeps a Buy rating on the shares. Published first on The...

Comments

Verra Mobility

Notizie

Ultime notizie per Verra Mobility (NASDAQ:VRRM) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO